A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
Clinical trial NCT06931717 · RECRUITING
Trial details
- NCT number
- NCT06931717
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-12
- Primary completion
- 2029-03-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.